Connect Biopharma(CNTB)
Focus: Connect Biopharma is a public immunology-focused pharmaceutical company headquartered in San Diego specializing in treatments for autoimmune diseases and inflammation. The company is in early-to-mid stage development with a public listing (CNTB) but generating modest near-term revenue.
Profile data last refreshed 8m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Connect Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Connect Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$26M
Key Products
Peak
Multi-indication marketed asset in respiratory disease but appears to be a commodity medical air product with limited differentiation and no disclosed Part D spending.
Products & Portfolio (3)
Help build intelligence for Connect Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.